SEARCH BY
| Category | Company |
|---|---|
| Founded | 1998 |
| Sector | Life Science |
| Employees | 114 |
| Revenue | 39M USD (2024) |
MaxCyte discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. MaxCyte was founded in 1998 and is headquartered in Rockville, Maryland.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |